If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number:(b)(4).
|
It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) procedure with a lassostar circular mapping catheter and a catheter shaft detached/broken inside the patient issue occurred.Initially it was reported that the heliostar internal lumen occluded.The procedure was not delayed due to the reported event.The procedure was completed successfully.No patient consequence was reported.Additional information was received on 12-may-2023.The interior of the heliostar was narrow.Its interior did not allow the lassostar circular mapping catheter to pass through it.The lassostar circular mapping catheter broke (kneed and broke the magnetic sensor) trying to pass inside the heliostar.No photo¿s were available.This event was originally considered non-reportable, however, bwi became aware of the lassostar circular mapping catheter broke (kneed and broke the magnetic sensor) on 12-may-2023 and have reassessed the event as reportable for a catheter shaft detached/broken inside the patient issue.
|
The investigation was completed on 06-jun-2023.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|